Keenova Announces Newly Updated Peyronie's Disease Study Results at American Urology Association Meeting

Go back to Keenova Announces Newly Updated Peyronie's Disease Study Results at American Urology Association Meeting
MALLINCKRODT PUBLIC LIMITED COMPANY (NYSE: MNK) Delayed: 0.34 --0 (-0%)
Previous Close $0.34    52 Week High $85.83 
Open $30.62    52 Week Low $50.90 
Day High $0.34    P/E 0.34 
Day Low $0.34    EPS $1.00 
Volume 84